H -tetrakis(2-hydroxyethyl)-1,4,7,10-tetrazacyclododecane)praseodymium(III) hexanitratopraseodymate(III) dihydrate
✦ LIBER ✦
Aqua[N,N′,N′′,N′′′-tetrakis(2-hydroxyethyl)-1,4,7,10-tetrazacyclododecane-κ4N]neodymium(III) tris(perchlorate) 1.25-hydrate
✍ Scribed by Richards-Johnson, Roxan U. ;Kahwa, Ishenkumba A. ;Lough, Alan J.
- Publisher
- International Union of Crystallography
- Year
- 2003
- Tongue
- English
- Weight
- 815 KB
- Volume
- 59
- Category
- Article
- ISSN
- 1600-5368
No coin nor oath required. For personal study only.
✦ Synopsis
H -tetrakis(2-hydroxyethyl)-1,4,7,10-tetrazacyclododecane-j 4 N]neodymium(III) tris(perchlorate) 1.25-hydrate
📜 SIMILAR VOLUMES
Aqua(N,N′,N′′,N′′′-tetrakis(2-hydroxyet
✍
Richards-Johnson, Roxan U. ;Kahwa, Ishenkumba A. ;Lough, Alan J.
📂
Article
📅
2003
🏛
International Union of Crystallography
🌐
English
⚖ 485 KB
{Δ-1,4,7,10-Tetrakis[(S)-2-hydroxyprop
✍
Smith, Christopher B. ;Lincoln, Stephen F. ;Taylor, Max R. ;Wainwright, Kevin P.
📂
Article
📅
2001
🏛
International Union of Crystallography
🌐
English
⚖ 381 KB
Crystallization of [Cd(S-thpc12)](ClO 4 ) 2 ÁH 2 O {S-thpc12 is 1,4,7,10-tetrakis[(S)-2-hydroxypropyl]-1,4,7,10-tetraazacyclo-dodecane} in the presence of sodium salicylate (sodium o-hydroxybenzoate) forms a receptor complex, namely the title compound, [Cd(C 20 H 44 N 4 O 4 )(C 7 H 5 O 3 )]ClO 4 Á0.
(1,4,7,10,13-Pentamethyl-1,4,7,10,13-pe
✍
Zhang, Feng ;Zhang, Jian-Rong ;Deng, Dao-Li ;Hage, Ronald
📂
Article
📅
2003
🏛
International Union of Crystallography
🌐
English
⚖ 390 KB